Related Experiment Video
Updated: Aug 11, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity
Tae-gyun Kim1, Jooyoung Jung, Matthew R Mysliwiec
1Department of Anatomy and Cardiovascular Research Center, University of Wisconsin Medical School, Madison, WI 53706, USA.
Insights
Jumonji (JMJ) represses alpha-cardiac myosin heavy chain (alphaMHC) gene expression by inhibiting myocyte enhancer factor 2 (MEF2) activity. This protein-protein interaction is crucial for regulating cardiac gene expression during development and disease.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Gene Regulation
Background:
- Alpha-cardiac myosin heavy chain (alphaMHC) gene expression is vital for heart development and function, decreasing in cardiac myopathy.
- Jumonji (JMJ) is essential for cardiovascular development and acts as a transcriptional repressor.
Purpose of the Study:
- To investigate the mechanism by which JMJ regulates alphaMHC expression.
- To determine the role of JMJ in repressing myocyte enhancer factor 2 (MEF2) activity.
Main Methods:
- Overexpression of JMJ in primary cardiomyocytes.
- Analysis of alphaMHC gene expression.
- Investigation of protein-protein interactions between JMJ and MEF2 isoforms.
Main Results:
- JMJ overexpression significantly reduced endogenous alphaMHC expression.
- JMJ repressed the synergistic activation of alphaMHC by MEF2 and thyroid hormone receptor (TR).
- JMJ directly interacted with MEF2A, inhibiting its transcriptional activity.
Conclusions:
- JMJ represses alphaMHC expression through direct physical interaction with MEF2A.
- This interaction mechanism is critical for regulating cardiac gene expression and may be relevant in cardiac disease states.
Abstract:
Expression of alpha-cardiac myosin heavy chain gene (alphaMHC) is developmentally regulated in normal embryonic hearts and down-regulated in cardiac myopathy and failing hearts. Jumonji (JMJ) has been shown to be critical for normal cardiovascular development and functions as a transcriptional repressor. Here, we demonstrate that JMJ represses alphaMHC expression through inhibition of myocyte enhancer factor 2 (MEF2) activity. In primary cardiomyocytes, overexpression of JMJ leads to marked reduction of endogenous alphaMHC expression. JMJ represses the synergistic activation of alphaMHC by MEF2 and thyroid hormone receptor (TR). Interestingly, JMJ inhibits transcriptional activities of all MEF2 isoforms, but not the TR-dependent activation. The transcriptional repression domain of JMJ interacts with the N-terminal part of MEF2A, resulting in the repression of MEF2A activities. These results suggest that JMJ represses alphaMHC expression via protein-protein interaction with MEF2A.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Inhibition of Cdk Activity
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Master Transcription Regulators
Inhibition of CDK Activity

